Mgo One Seven LLC Intellia Therapeutics, Inc. Transaction History

Mgo One Seven LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 09, 2019	SELL	$12.79 - $17.62 $26,859 - $37,002	-2,100 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$11.39 - $27.13 $23,919 - $56,973	2,100 New	2,100 $28,000
Q3 2018 Oct 09, 2018	SELL	$25.78 - $32.6 $54,138 - $68,460	-2,100 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$17.39 - $31.12 $36,519 - $65,352	2,100	2,100 $40,000

317

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $835M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.